B2B ad examples

Are inconsistent results from your DIY antibody conjugation leaving you guessing? Skip the hassle. Draw the right conclusion the first time by choosing CST for your custom conjugation. CST Custom Conjugation Services provide exceptional quality antibody conjugates with the label you need—including fluorescent dyes, biotin, oligos, europium, HRP, and beads—made by conjugation experts with the clones you trust.

Every additional antibody in your multiomics and multiplex workflows increases variability, complexity, and risk. That’s why every antibody has to keep pace. Scaling discovery means getting more from every precious sample, not risking it on reagents that might not hold up. Download the infographic to learn how CST® antibodies can help you scale discovery with confidence.

Before your next Go/No Go decision: join CN Bio's free e-symposium 'From Insight to Decision'. Expert-led sessions on model development, DMPK, tox, plus a masterclass to get you started. Click below to register!

Spot risks earlier to make better efficacy, DMPK and tox decisions. Learn how leading R&D teams use Organ-on-a-chip at CN Bio's free e-symposium this December. Click below to register!

El 56º Congreso de la Sociedad Española de Nefrología será el marco de nuestro simposio sobre nefropatía por IgA. ¿Cómo trasladar las guías a la práctica clínica real? Las Dras. Marian Goicoechea, Ana Ávila y Clara García abordarán esta cuestión en el encuentro. 🗓️ Viernes 6 de noviembre 🕝 14:30–15:25 h 📍 Sala multiusos 2A ¡Os esperamos!

Kaygılı anlarda nefes alışını doğru yönetmeye ne dersin? 🌿 Stres veya kaygı anında 4 saniye burnunuzdan nefes alın, 7 saniye nefesinizi tutun ve 8 saniyede ağzınızdan yavaşça verin. Bu döngüyü 4 kez tekrarlamak, parasempatik sinir sistemini (vücudun sakinleşme mekanizmasını) doğrudan devreye sokarak nabzı düzenleyip gerginliği düşürür. 💙 #DaiichiSankyo #İyiGelir

𝐔𝐰 𝐟𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐬𝐜𝐡𝐞 𝐤𝐥𝐚𝐧𝐭 𝐬𝐭𝐞𝐥𝐭 𝐬𝐭𝐞𝐞𝐝𝐬 𝐡𝐨𝐠𝐞𝐫𝐞 𝐞𝐢𝐬𝐞𝐧 𝐚𝐚𝐧 𝐮𝐰 𝐨𝐩𝐬𝐥𝐚𝐠𝐜𝐨𝐧𝐝𝐢𝐭𝐢𝐞𝐬. 𝐁𝐞𝐧𝐭 𝐮 𝐚𝐚𝐧𝐭𝐨𝐨𝐧𝐛𝐚𝐚𝐫 𝐜𝐨𝐦𝐩𝐥𝐢𝐚𝐧𝐭? Logistiek dienstverleners die farmaceutische producten opslaan of distribueren weten het: de eisen van opdrachtgevers nemen toe. Een URS, periodieke audits, rapportageverplichtingen en soms directe inzage in het temperatuurbewakingssysteem. Voor de QA-afdeling betekent dit een groeiende administratieve last, zeker als de onderliggende systemen die transparantie niet kunnen bieden. Wat wij in de praktijk zien, is dat wie niet aantoonbaar compliant is, steeds vaker te maken krijgt met kortere audit intervallen en aanvullende documentatieverzoeken. In het uiterste geval staat de opdracht zelf ter discussie. Maar er is ook een andere kant van dit verhaal. Logistiek dienstverleners die hun koudeketen realtime en volledig gevalideerd bewaken, onderscheiden zich op het moment dat het er echt toe doet: aan tafel bij een nieuwe opdrachtgever. Wat wij terughoren van onze klanten, is dat opdrachtgevers het als een groot pluspunt zien als de opdrachtnemer hier al serieus over heeft nagedacht. Dyzle EMS biedt de mogelijkheid om opdrachtgevers directe inzage te geven in gevalideerde temperatuurdata, volledig in te richten via gebruikersbeheer en autorisaties. Zo is transparantie geen inspanning maar een gegeven. Meer weten over wat Dyzle Services B.V. voor logistiek dienstverleners kan betekenen? Kijk op onze website. #GDP #koudeketen #temperatuurbewaking #logistiek #kwaliteitsborging

𝗧𝗵𝗶𝘀 𝗕𝗿𝗲𝗮𝘀𝘁 𝗖𝗮𝗻𝗰𝗲𝗿 𝗔𝘄𝗮𝗿𝗲𝗻𝗲𝘀𝘀 𝗠𝗼𝗻𝘁𝗵, 𝘄𝗲 𝗿𝗲𝗰𝗼𝗴𝗻𝗶𝘇𝗲 𝘁𝗵𝗲 𝗼𝗻𝗴𝗼𝗶𝗻𝗴 𝗻𝗲𝗲𝗱 𝗳𝗼𝗿 𝗻𝗲𝘄 𝗮𝗻𝗱 𝗺𝗼𝗿𝗲 𝗲𝗳𝗳𝗲𝗰𝘁𝗶𝘃𝗲 𝗯𝗿𝗲𝗮𝘀𝘁 𝗰𝗮𝗻𝗰𝗲𝗿 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁𝘀. Here, we’re sharing one example of how BioDuro’s Biology team supports research in this field. Our in vitro assay panel supports the evaluation of ERα-BRD4 RIPTACs, which are designed to bring ERα and BRD4 together and leverage ERα expression to selectively disrupt BRD4 function in breast cancer cells. The panel examines whether Erα-BRD4 complex formation is accompanied by the expected functional changes. Comparing growth inhibition in ER-positive and ER-negative models adds insight into potential selectivity, helping researchers interpret differences in compound activity and prioritize compounds for further study. Interested in learning more about our Biology team’s work in this area? Send us a message - [email protected] #BreastCancerAwarenessMonth #RIPTAC #DrugDiscovery #Biology

Vóór 17.00 uur het recept ingestuurd? Dan verzenden we de medicijnen dezelfde dag nog naar je patiënt. Snel, veilig en zonder gedoe. Spoed? We leveren binnen 4 uur door heel Nederland (m.u.v. de Waddeneilanden). Maak kennis met Nationale Apotheek.

Met een receptkoppeling stuur je recepten direct door naar Nationale Apotheek vanuit je eigen HIS of ZIS. Geen extra handelingen, geen losse mailtjes. We kunnen alle gangbare systemen koppelen en helpen je bij het inrichten. Zo kun je snel aan de slag en weet je zeker dat elk recept op de juiste plek binnenkomt. Maak kennis met Nationale Apotheek.

What makes a drug target worth pursuing? Human genetics is increasingly part of the answer. A new Nature Genetics study analyzed exomes from 44,028 British Pakistani and Bangladeshi participants, uncovering 100+ novel gene-phenotype associations and nearly 3,000 human knockout genes. One finding stands out for drug developers: drugs targeting genes with knockouts in adults were associated with a 2.2x higher likelihood of progressing beyond Phase 1 clinical trials. Built on saliva samples using the Oragene™ collection kits, this resource highlights how scalable, participant-friendly sampling can generate the diverse datasets needed to inform target selection. At DNA Genotek, we're proud to support research that advances our understanding of human genetics and helps inform drug discovery and development. Read the study: https://lnkd.in/eAuXxq6R #HumanGenetics #DrugDiscovery #TargetValidation #Genomics #PrecisionMedicine

🦠 1 in 10 adults may be affected by functional dyspepsia. But what role does the gut microbiota play in this digestive disorder? Early satiety, pain or burning sensations in the upper abdomen, discomfort after meals… Functional dyspepsia is a chronic disorder of gut-brain interaction that often remains underdiagnosed. While several mechanisms may contribute to its development, research also suggests a possible link with gut microbiota imbalance, particularly in the duodenum. But how can this relationship be explained? And which approaches may help relieve symptoms and improve patients' quality of life? 🔎 Discover our new infographic to learn more about the symptoms of functional dyspepsia, the role of the gut microbiota, and the different management approaches. 👩⚕️ An educational tool designed to support healthcare professionals in their discussions with patients and help them better understand this digestive disorder. Explore all our microbiota-related infographics on our website: https://lnkd.in/eP5bfYgt #GutMicrobiota #FunctionalDyspepsia #GutBrainAxis #DigestiveHealth #MicrobiotaResearch

Scientific innovation only matters if the data supports it. In this conversation, Laura Lotfi explains how Virtual Control Groups are evaluated, validated, and applied to support informed decision-making in drug development. Watch the discussion and learn why VCGs continue to gain attention across the non-clinical research community: https://bit.ly/4xAy6O5

Praxisnahe Fortbildung, interdisziplinärer Austausch und wissenschaftliche Erkenntnisse aus der modernen Krebsmedizin. Am 6. und 7. November 2026 findet die I-HO Academy: Jahres-tagung 2026 in Berlin statt! Neben einem breiten, tumorübergreifenden Programm freuen wir uns besonders auf zwei interaktive Seminarblöcke speziell für die Hämatologie: 🩸 Freitag, 6. November (18:00 Uhr): „Aus dem Blickwinkel von Praxis und Klinik: Aktuelle Therapien der Hodgkin- und Non-Hodgkin-Lymphome“ ➡️ Wie verändern innovative State-of-the-art-Therapien die Versorgungsstrukturen? Wir be-leuchten den dynamischen Wandel in der Behandlung der Hodgkin- und Non-Hodgkin-Lymphome aus Praxis- und Klinikperspektive. 🩸 Samstag, 7. November (10:30 Uhr): „Multiples Myelom und MDS – Therapieoptionen zwi-schen Evidenz und Innovation“ ➡️ Neue Ansätze, zunehmend komplexe Therapiesequenzen und stetig wachsende Evidenz stellen hohe Anforderungen an die klinische Entscheidungsfindung. Anhand interaktiver Fall-beispiele können Sie die Therapiewahl gemeinsam mit unseren Expert:innen reflektieren. Die Veranstaltung im Überblick: 📅 Wann? Freitag, 6. November (ab 16:00 Uhr) bis Samstag, 7. November 2026 (14:00 Uhr) 📍 Wo? Hotel Crowne Plaza Berlin | City Centre Ku'damm oder virtuell via Livestream 👉 Melden Sie sich jetzt an, stellen Sie ihr individuelles Fortbildungsprogramm zusammen und profitieren Sie von Diskussionen mit Kolleg:innen aus Klinik und Praxis: https://lnkd.in/e4ja8MZR Wir freuen uns darauf, Sie in Berlin oder im Livestream begrüßen zu dürfen! #IHOAcademy #BMSgermany #Hämatologie

What builds confidence in a new scientific approach? Evidence. In this interview, Laura Lotfi discusses the validation work, data, and scientific considerations helping advance the conversation around Virtual Control Groups (VCGs). Watch the discussion and learn how researchers are evaluating VCG implementation in non-clinical development: https://bit.ly/4ymKbXI

Also in Madrid for ESMO 2026? Whether your focus is lung, prostate, bladder, gastrointestinal or skin cancers, our Belgian team looks forward to exchanging with you on the latest developments in your field. Visit our booth #8069 in Hall 8, open throughout the congress, or join us for a dedicated meet-up with the Belgian team on Monday 26 October between 13:00 and 14:00. #bmsbelgium *This content is intended for prescribing HCPs only. ONC-BE-2600158-Oct-2026

Whether you're optimizing a lead candidate or advancing a preclinical program, actionable insights can make all the difference. Discover how integrated RNA design, prototyping, and sequencing-based analytics can help accelerate development and reduce uncertainty. Learn more: https://lnkd.in/gkRbyqNu/?utm_campaign=SupremeOptimization&utm_source=linkedin&utm_medium=paid&utm_id=779370846&hsa_acc=513272138&hsa_cam=779370846&hsa_grp=917079086&hsa_ad=1653055376&hsa_net=linkedin&hsa_ver=3

From sequence optimization to translational performance, access the expertise and analytics needed to make smarter RNA development decisions. Learn more: https://lnkd.in/gkRbyqNu/?utm_campaign=SupremeOptimization&utm_source=linkedin&utm_medium=paid&utm_id=779370846&hsa_acc=513272138&hsa_cam=779370846&hsa_grp=917079086&hsa_ad=1653131636&hsa_net=linkedin&hsa_ver=3

The right patients for the #DETOURSystem are already in your practice. Explore the positive clinical outcomes for percutaneous transmural arterial bypass (#PTAB) with the DETOUR System in patients with long, complex SFA disease, including 4 patient types underserved by traditional treatment options. 🌎 https://lnkd.in/gV8EnE_3 Safety Info: https://lnkd.in/gsfj52-H Rhevera Medical Holdings is the parent company of Endologix LLC. Endologix LLC is the legal manufacturer of the company's devices. #medtech #healthinnovation #PeripheralArteryDisease

What does progress in speech therapy look like? Our very own speechie and Clinical Operations Manager, Sophia, explains it like a tree. 🌳 The roots keep growing the whole way, so every stage counts. Learn more: https://lnkd.in/ewNu_Ham #AlliedKidsTherapy #SpeechPathology #SpeechTherapy #paediatrics #alliedhealth #childdevelopment

Human-relevant cardiac models can help researchers study cardiovascular biology, disease mechanisms and drug-induced cardiotoxicity. The Cardiomyocyte portfolio provides human iPSC-derived atrial and ventricular cardiomyocytes with distinct chamber-specific phenotypes and functional properties. The cells support contractility studies, electrophysiology, disease modelling and cardiac safety research across 2D and 3D systems.

Studying atrial biology and cardiovascular disease requires human-relevant models with distinct chamber-specific characteristics. Human iPSC-derived myrCell Atrial Cardiomyocytes form electrically coupled monolayers and demonstrate spontaneous, synchronised contractions within 7 days post-thaw. With characteristic atrial electrophysiology and ion channel profiles, they support applications including electrophysiology, pharmacological screening, disease modelling and atrial fibrillation research.

Four-class GDMT prescribing in systolic heart failure has more than doubled since 2023, from 9% to 21%. However, gaps persist: 79% of systolic HF patients are not on four-class GDMT, and the average health system has roughly 1,050 systolic HF patients on no GDMT. Our 2026 Benchmark Report draws on de-identified data from more than 15.7 million patients across 47 U.S. health systems to show where therapy adoption is moving, how widely it varies by site, and how three-year survival is associated with the number of GDMT classes prescribed. Download the full report: https://lnkd.in/g5Xs7jPT #RealWorldEvidence #HeartFailure #HFrEF #GDMT

Today, we’re proud to launch CORE 300™, our newest FDA-cleared, AI-enabled digital stethoscope. In a world where cardiovascular diseases remain the leading cause of death, we believe every physical exam is an opportunity to help detect heart and lung disease earlier. And it starts with the most ubiquitous medical device. Every clinician deserves a device that makes them more confident in their clinical care. CORE 300 Digital Stethoscope is the first to bring traditional and digital listening together in a single chestpiece, engineered to put Eko’s advanced digital capabilities into the familiar form clinicians already know and use every day. When connected to the Eko App, clinicians can access Eko’s FDA-cleared AI for structural murmur detection.* “Using CORE 300, what stood out to me was how much more capability it brings to a physical exam that still feels familiar,” said Jerome Adams, MD, 20th U.S. Surgeon General. “Clearer listening and more clinical information at the point of care can help clinicians recognize concerning findings earlier and make more informed decisions.” CORE 300 is available now on ekohealth.com Read our full announcement here: https://lnkd.in/eMzjUA3d/?utm_campaign=Boost_Post_VideoViews_Oct22,2026&utm_source=linkedin&utm_medium=paid&utm_id=1236454316&hsa_acc=500839872&hsa_cam=1236454316&hsa_grp=917278726&hsa_ad=1656801806&hsa_net=linkedin&hsa_ver=3 *CORE 300 is FDA-cleared in the U.S. (K261694). Structural murmur detection requires Eko+ and the Eko App (K251494). Availability varies by market.